Published January 1, 2022 | Version v1
Journal article Open

Synthesis and anticancer activity of novel hydrazone linkage-based aryl sulfonate derivatives as apoptosis inducers

  • 1. Marmara Univ, Fac Pharm, Dept Pharmaceut Chem, TR-34854 Istanbul, Turkey
  • 2. Erciyes Univ, Fac Pharm, Dept Pharmaceut Chem, TR-38280 Kayseri, Turkey
  • 3. Marmara Univ, Fac Pharm, Dept Biochem, TR-34854 Istanbul, Turkey
  • 4. Fenerbahce Univ, Vocat Sch Hlth Serv, TR-34758 Istanbul, Turkey

Description

In the present study, the various 28 hybrid molecules containing hydrazone and sulfonate moieties were synthesized and characterized by FTIR, H-1-NMR, C-13-NMR spectroscopy and LC-MS spectrometry, besides elemental analysis. The compounds were evaluated for their antiproliferative effects against six cancer cell lines, namely A549 (non-small cell lung cancer), MCF-7 (breast cancer), HT-29 (colorectal adenocarcinoma cancer), PC-3 (androgen-independent prostate adenocarcinoma), Hep3B (hepatocellular carcinoma cancer), and HeLa (epitheloid cervix carcinoma cancer). Among all the target compounds, compounds 4g and 4h exhibited more promising effects on MCF-7 cell lines (IC50 = 17.8 mu M and 21.2 mu M, respectively) with high selectivity. Further mechanistic studies proposed that compounds 4g and 4h induced apoptosis is mediated through the intrinsic apoptotic pathway with changes in mitochondrial membrane potential by finally activating caspase-9 and caspase-3. The results have been encouraging enough to merit further investigation.

Files

bib-d5f80961-1bbb-4d9e-87c4-31251d303660.txt

Files (238 Bytes)

Name Size Download all
md5:e349bcee4b1bdba8e46d4c1dd738c150
238 Bytes Preview Download